查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601139

眼科市場：按疾病、產品類型、最終用戶分類 - 全球預測 2025-2030

Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses & Lens), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年眼科市值為597.8億美元，預計到2024年將達到637.2億美元，複合年成長率為6.62%，到2030年將達到936.9億美元。

眼科是醫學和外科的一個分支，專門從事眼科疾病的診斷和治療，並且由於技術的進步和眼科疾病盛行率的增加而正在發生重大變化。眼科市場範圍包括手術器械、診斷工具、矯正鏡片以及用於治療青光眼、白內障、老齡化黃斑部病變和糖尿病視網膜病變等疾病的藥物療法。世界人口老化、糖尿病患者數量增加以及螢幕時間增加（導致眼睛疲勞和視力問題）凸顯了對創新眼科解決方案的需求。影響眼科市場的關鍵成長要素包括診斷領域的人工智慧和機器學習等快速技術創新、微創手術技術的開拓以及研發投資的激增。遠距眼科是一個充滿希望的機會，它可以增強偏遠地區的眼科護理服務並最佳化臨床工作流程。基因療法和個人化醫療也透過針對影響視力的遺傳性疾病提供變革潛力。然而，該市場面臨一些限制，例如與先進治療和設備相關的高成本、嚴格的監管指南以及缺乏熟練的專業人員。這些挑戰需要適應性策略，例如具有成本效益的設備開發和監管流程導航。創新和研究的熱門領域包括智慧隱形眼鏡、人工智慧驅動的診斷工具和視網膜掃描的進步，這些領域有望改善眼科疾病的早期檢測和治療。市場格局的特點是競爭格局需要不斷創新和適應，以因應新趨勢和患者需求。為了利用這些機會，公司正在投資研發，優先考慮技術進步的夥伴關係，並改善護理服務，同時解決成本問題並改善全球眼科保健服務的可及性。方案上，以加強。

主要市場統計
基準年[2023] 597.8億美元
預測年份 [2024] 637.2億美元
預測年份 [2030] 936.9億美元
複合年成長率（%） 6.62%

市場動態：揭示快速發展的眼科市場的關鍵市場洞察

供需的動態交互作用正在改變眼科市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 眼部疾病的盛行率和公眾意識的提高
    • 處方眼鏡和處方鏡片的採用率增加
    • 擁有設備齊全的醫療基礎設施和增加的藥品核准
  • 市場限制因素
    • 眼科治療費用上漲
  • 市場機會
    • 眼保健領域的新興研究活動和津貼情況
    • 透過眼科技術整合實現高可用性
  • 市場挑戰
    • 缺乏熟練的眼保健專家

波特五力：駕馭眼科市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解眼科市場的外部影響

外部宏觀環境因素對眼科市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解眼科市場的競爭狀況

眼科市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣眼科市場供應商績效評估

FPNV定位矩陣是評估眼科市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 規劃眼科市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，眼科市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 眼科疾病的傳播與公眾意識的提高
      • 處方眼鏡和鏡片的採用率增加
      • 擁有設備齊全的醫療基礎設施和不斷增加的藥品核准數量
    • 抑制因素
      • 眼科治療費用高
    • 機會
      • 眼科護理的新研究活動和津貼
      • 眼科技術整合可實現高可用性
    • 任務
      • 眼科手術專家數量有限
  • 市場區隔分析
    • 疾病：很大一部分人口患有屈光不正，例如近視、遠視、散光和老花眼。
    • 產品類型：加大眼科軟體開發投入
    • 最終用戶：世界各地醫療機構的持續研究活動
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依疾病分類的眼科市場

  • 老齡化黃斑部病變
  • 白內障
  • 青光眼
  • 發炎疾病
  • 屈光不正

第7章眼科市場：依產品類型

  • 藥物
    • 過敏性結膜炎及發炎治療
    • 乾眼症藥
    • 青光眼醫學
    • 視網膜疾病治療藥物
  • 裝置
    • 診斷設備
    • 手術設備
      • 人工水晶體
      • 眼科雷射
  • 處方眼鏡和鏡片
  • 軟體

第8章眼科市場：依最終使用者分類

  • 醫療保健服務供應商
  • 醫院
  • 醫療機構
  • 調查機構

第9章 北美和南美眼科市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太眼科市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲眼科市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Beacon Therapeutics 獲得 1.7 億美元 B 輪資金籌措，以在全球範圍內推進和擴大眼科基因治療
    • Thea Pharma Co., Ltd.引進新資源為拉坦前列素眼藥水患者提供支持
    • BioPhta 已籌集 650 萬歐元，用於將其創新的眼科疾病治療方法推進臨床試驗並在全球推廣。
    • Clario 和 EmSere 結成策略聯盟，透過先進的影像和資料整合徹底改變眼科臨床試驗
    • Biocon Biologics Limited 的生物相似藥阿柏西普獲得美國FDA核准，並進軍美國眼科市場
    • Topcon 和 Microsoft 合作，透過人工智慧驅動的醫療平台徹底改變眼部診斷
    • Eye2Gene Limited 與 Heidelberg Engineering, Inc. 在 ARVO 2024 上宣布合作
    • Nordic Pharma, Inc. 準備在 ASCRS 年會上推出 LACRIFILL
    • Clario 和克利夫蘭診所基金會的科爾眼科研究所已建立策略夥伴關係，以加強臨床試驗。
    • Refocus Eye Health 與新澤西州八家頂級醫療機構合作，以增強我們的專業眼科保健服務。
    • Ikerian AG 推出發現核心平台，為眼科資料分析提供支持
    • Cipla 與 CSIR-CDRI 合作創新眼科抗真菌治療，加速研發和全球市場滲透。
  • 戰略分析和建議
    • 愛爾康有限公司
    • 依視路 Lux Otica SA
    • 艾伯維公司
    • 博士倫公司

公司名單

  • AbbVie Inc.
  • Alcon Inc.
  • Alkeus Pharmaceuticals, Inc.
  • Apotex Inc.
  • Bausch+Lomb Corporation
  • CH Boehringer Sohn AG & Co. KG
  • Carl Zeiss AG
  • ClearSight LLC
  • CooperVision, Inc.
  • Duopharma Biotech Berhad
  • Essex Bio-Technology Limited
  • EssilorLuxottica SA
  • Eyenovia, Inc.
  • F. Hoffmann-La Roche AG
  • GenSight Biologics SA
  • Geri-Care Pharmaceuticals Corp.
  • Glaukos Corporation
  • Halma PLC
  • Harrow Health, Inc.
  • Honeywell International Inc.
  • Hoya Corporation
  • Johnson & Johnson Services Inc.
  • Kubota Pharmaceutical Holdings Co., Ltd.
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • OCuSOFT, Inc.
  • Oxurion NV
  • Pfizer, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • SEED Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Topcon Corporation
  • Unimed Pharma, Spols ro
  • Visioncare Optolab Pvt. Ltd.
Product Code: MRR-4348D129FA96

The Ophthalmology Market was valued at USD 59.78 billion in 2023, expected to reach USD 63.72 billion in 2024, and is projected to grow at a CAGR of 6.62%, to USD 93.69 billion by 2030.

Ophthalmology, the branch of medicine and surgery dedicated to the diagnosis and treatment of eye disorders, is witnessing a significant transformation driven by technological advancements and increasing prevalence of eye diseases. The market scope for ophthalmology encompasses surgical devices, diagnostic tools, corrective lenses, and medication aimed at treating conditions like glaucoma, cataracts, age-related macular degeneration, and diabetic retinopathy. The necessity for innovative ophthalmological solutions is underscored by the aging global population, rising diabetes cases, and increased screen time, contributing to eye strain and vision problems. end-use segments primarily include hospitals, ambulatory surgical centers, and specialized eye clinics. Key growth factors influencing the ophthalmology market include rapid technological innovations such as AI and machine learning in diagnostics, development of minimally invasive surgical techniques, and an upsurge in R&D investments. A promising opportunity lies in tele-ophthalmology, which can enhance access to eye care in remote areas and optimize practice workflows. Gene therapy and personalized medicine also present transformative potential by targeting genetic disorders affecting vision. However, the market faces limitations like high costs associated with advanced treatments and devices, stringent regulatory guidelines, and a shortage of skilled professionals. These challenges necessitate adaptive strategies, such as cost-effective device development and regulatory process navigation. The best areas for innovation and research involve smart contact lenses, AI-powered diagnostic tools, and advancements in retinal scans, which promise improved early detection and treatment of eye conditions. The ophthalmology market's nature is characterized by its competitive landscape, which demands continuous innovation and adaptation to meet emerging trends and patient needs. To leverage these opportunities, businesses should invest in R&D, prioritize partnerships for technological advancement, and focus on patient-centric solutions that enhance care delivery while addressing cost concerns and improving access to eye care services globally.

KEY MARKET STATISTICS
Base Year [2023] USD 59.78 billion
Estimated Year [2024] USD 63.72 billion
Forecast Year [2030] USD 93.69 billion
CAGR (%) 6.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmology Market

The Ophthalmology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of eye disorders and growing awareness among the population
    • Increasing adoption of prescription glasses and lenses
    • Presence of well-equipped healthcare infrastructure and an increasing number of drug approvals
  • Market Restraints
    • High cost of ophthalmologic treatments
  • Market Opportunities
    • Emerging research activities of ophthalmology treatments and availability of grants
    • High usage potential owing to the technological integrations in Ophthalmology
  • Market Challenges
    • Limited skilled professionals for ophthalmic procedures

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmology Market

A detailed market share analysis in the Ophthalmology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmology Market

A strategic analysis of the Ophthalmology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmology Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch + Lomb Corporation, C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight LLC, CooperVision, Inc., Duopharma Biotech Berhad, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd., Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Topcon Corporation, Unimed Pharma, Spols r.o., and Visioncare Optolab Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Ophthalmology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Diseases, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.
  • Based on Product Type, market is studied across Drugs, Equipment, Prescription Glasses & Lens, and Software. The Drugs is further studied across Allergic Conjunctivitis & Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. The Equipment is further studied across Diagnostic Devices and Surgical Devices. The Surgical Devices is further studied across Intraocular Lenses and Ophthalmic Lasers.
  • Based on End User, market is studied across Healthcare Service Providers, Hospitals, Medical Institutes, and Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of eye disorders and growing awareness among the population
      • 5.1.1.2. Increasing adoption of prescription glasses and lenses
      • 5.1.1.3. Presence of well-equipped healthcare infrastructure and an increasing number of drug approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of ophthalmologic treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging research activities of ophthalmology treatments and availability of grants
      • 5.1.3.2. High usage potential owing to the technological integrations in Ophthalmology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited skilled professionals for ophthalmic procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Diseases: Prevalence of refractive errors such as myopia, hyperopia, astigmatism, and presbyopia in a significant portion of the population
    • 5.2.2. Product Type: Increasing investments in software development in ophthalmology
    • 5.2.3. End User: Continuous research activities by medical institutes worldwide
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ophthalmology Market, by Diseases

  • 6.1. Introduction
  • 6.2. Age-Related Macular Degeneration
  • 6.3. Cataract
  • 6.4. Glaucoma
  • 6.5. Inflammatory Diseases
  • 6.6. Refractive Disorders

7. Ophthalmology Market, by Product Type

  • 7.1. Introduction
  • 7.2. Drugs
    • 7.2.1. Allergic Conjunctivitis & Inflammation Drugs
    • 7.2.2. Dry Eye Drugs
    • 7.2.3. Glaucoma Drugs
    • 7.2.4. Retinal Disorder Drugs
  • 7.3. Equipment
    • 7.3.1. Diagnostic Devices
    • 7.3.2. Surgical Devices
      • 7.3.2.1. Intraocular Lenses
      • 7.3.2.2. Ophthalmic Lasers
  • 7.4. Prescription Glasses & Lens
  • 7.5. Software

8. Ophthalmology Market, by End User

  • 8.1. Introduction
  • 8.2. Healthcare Service Providers
  • 8.3. Hospitals
  • 8.4. Medical Institutes
  • 8.5. Research Organizations

9. Americas Ophthalmology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Beacon Therapeutics secures USD 170 Million in series B funding to propel ophthalmic gene therapies and drive global expansion
    • 12.3.2. Thea Pharma Inc. introduced new resources to support latanoprost ophthalmic solution patients
    • 12.3.3. BioPhta raises EUR 6.5 million to propel innovative eye disease treatments to clinical trials and expand global reach
    • 12.3.4. Clario and EmSere forge strategic partnership to revolutionize ophthalmic clinical trials with advanced imaging and data integration
    • 12.3.5. Biocon Biologics Limited received U.S. FDA approval for biosimilar aflibercept, enters U.S. ophthalmology market
    • 12.3.6. Topcon and Microsoft join forces to revolutionize ophthalmic diagnostics with AI-powered healthcare platform
    • 12.3.7. A collaboration between Eye2Gene Limited and Heidelberg Engineering, Inc. was announced at ARVO 2024
    • 12.3.8. Nordic Pharma, Inc. gears up for LACRIFILL launch at ASCRS annual meeting
    • 12.3.9. Clario and Cleveland Clinic Foundation's Cole Eye Institute formed a strategic partnership for enhanced ophthalmology clinical trials
    • 12.3.10. Refocus Eye Health is partnering with eight premier practices in New Jersey to enhance specialized eye services
    • 12.3.11. Ikerian AG unveiled a discovery core platform for enhanced ophthalmic data analysis
    • 12.3.12. Cipla joins forces with CSIR-CDRI to innovate ophthalmic antifungal treatments, accelerating R&D and global market reach
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Alcon Inc.
    • 12.4.2. EssilorLuxottica S.A.
    • 12.4.3. AbbVie Inc.
    • 12.4.4. Bausch + Lomb Corporation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Alcon Inc.
  • 3. Alkeus Pharmaceuticals, Inc.
  • 4. Apotex Inc.
  • 5. Bausch + Lomb Corporation
  • 6. C.H. Boehringer Sohn AG & Co. KG
  • 7. Carl Zeiss AG
  • 8. ClearSight LLC
  • 9. CooperVision, Inc.
  • 10. Duopharma Biotech Berhad
  • 11. Essex Bio-Technology Limited
  • 12. EssilorLuxottica S.A.
  • 13. Eyenovia, Inc.
  • 14. F. Hoffmann-La Roche AG
  • 15. GenSight Biologics S.A.
  • 16. Geri-Care Pharmaceuticals Corp.
  • 17. Glaukos Corporation
  • 18. Halma PLC
  • 19. Harrow Health, Inc.
  • 20. Honeywell International Inc.
  • 21. Hoya Corporation
  • 22. Johnson & Johnson Services Inc.
  • 23. Kubota Pharmaceutical Holdings Co., Ltd.
  • 24. Lumenis Be Ltd.
  • 25. Nidek Co., Ltd.
  • 26. Novartis AG
  • 27. OCuSOFT, Inc.
  • 28. Oxurion NV
  • 29. Pfizer, Inc.
  • 30. Santen Pharmaceutical Co., Ltd.
  • 31. SEED Co., Ltd.
  • 32. Sun Pharmaceutical Industries Limited
  • 33. Teva Pharmaceutical Industries Ltd.
  • 34. Topcon Corporation
  • 35. Unimed Pharma, Spols r.o.
  • 36. Visioncare Optolab Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. OPHTHALMOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. OPHTHALMOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPHTHALMOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPHTHALMOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023